Answers are grounded in this paper and cite their sources.
Shows plant-based antibodies reduce mpox virus infection, indicating a novel therapeutic approach.
Recent mpox outbreaks in non-endemic countries highlight the need for improved therapeutics and diagnostics. In this study, monoclonal antibodies (mAbs) targeting the mpox enveloped virion antigens A35 and B6 were transiently expressed in Nicotiana benthamiana using a geminiviral vector system. Following agroinfiltration, anti-A35 and anti-B6 mAbs accumulated to 27 ± 15 µg/g fresh weight at 3 days and 260 ± 90 µg/g at 7 days post-infiltration, respectively. SDS-PAGE and Western blot analyses confirmed proper antibody assembly. Purified antibodies specifically recognized mpox-infected Vero cells and showed moderate neutralizing activity, reducing viral infection by 91 ± 5% for anti-A35 and 71 ± 10% for anti-B6. Additionally, an electrochemical immunosensor demonstrated the ability of plant-produced antibodies to detect mpox virus through antigen–antibody binding induced current changes. These results support that the plant-based systems as rapid platforms for producing mpox-specific antibodies for diagnostics and antiviral research.
No takes yet. Share an insight, caveat, or question.
Jirananon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: